We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Genmab Licenses DuoBody Platform to Novo Nordisk

News   Aug 17, 2015

 
Genmab Licenses DuoBody Platform to Novo Nordisk
 
 
 

RELATED ARTICLES

Promise for an HIV Vaccine

News

An experimental vaccine strategy against HIV has been shown to work in non-human primates.

READ MORE

Vaccination May Reduce Flu Severity in Vaccinated Patients

News

Vaccination may reduce the severity of the flu in vaccinated but still infected patients.

READ MORE

Portable Ebola Test Brings Quicker Diagnosis to Remote Regions

News

Researchers have created a portable and fast-acting test that can distinguish Ebola infections from other fever-causing infectious diseases such as Lassa fever and malaria in around 30 minutes. Although further testing is required, this could be useful during febrile disease outbreaks.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE